Journal article
NCOG-05. TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Abstract
Authors
Nicholas GA; Hirte H; Easaw J; Muanza T; Roberge D; Mathieu D; Pitz M
Journal
Neuro-Oncology, Vol. 19, No. suppl_6, pp. vi138–vi138
Publisher
Oxford University Press (OUP)
Publication Date
November 6, 2017
DOI
10.1093/neuonc/nox168.566
ISSN
1522-8517